• Fri, November 17, 2017

by: WOPRAI

Jason Gurda Initiated (AMN) at Buy and Held Target at $50 on, Nov 17th, 2017

by: WOPRAI

Michael Nemeroff Maintained (ADSK) at Buy with Increased Target to $140 on, Nov 17th, 2017

by: WOPRAI

Tom Abrams Maintained (AM) at Hold with Decreased Target to $37 on, Nov 17th, 2017

by: WOPRAI

Weston Twigg Maintained (AMAT) at Buy with Increased Target to $67 on, Nov 17th, 2017

by: WOPRAI

Sidney Ho Maintained (AMAT) at Strong Buy with Increased Target to $65 on, Nov 17th, 2017

by: WOPRAI

Krish Sankar Maintained (AMAT) at Strong Buy with Increased Target to $80 on, Nov 17th, 2017

by: WOPRAI

Joseph Moore Maintained (AMAT) at Buy with Increased Target to $61 on, Nov 17th, 2017

by: WOPRAI

Rod Lache Maintained (BBY) at Hold with Decreased Target to $56 on, Nov 17th, 2017

by: WOPRAI

Simon Flannery Maintained (BCE) at Hold with Increased Target to $62 on, Nov 17th, 2017

by: WOPRAI

Debbie Jones Maintained (BERY) at Strong Buy with Increased Target to $66 on, Nov 17th, 2017

by: WOPRAI

Tom Abrams Maintained (TRP) at Hold with Increased Target to $54 on, Nov 17th, 2017

by: WOPRAI

Jennifer Cook Upgraded (TRU) to Buy on, Nov 17th, 2017

by: WOPRAI

Brent Bracelin Maintained (BL) at Buy with Increased Target to $46 on, Nov 17th, 2017

by: WOPRAI

Simon Flannery Maintained (TU) at Hold with Increased Target to $26 on, Nov 17th, 2017

by: WOPRAI

Fotis Giannakoulis Maintained (STNG) at Buy with Decreased Target to $50 on, Nov 17th, 2017

by: WOPRAI

Tazeen Ahmad Maintained (ASND) at Strong Buy with Decreased Target to $43 on, Nov 17th, 2017

by: WOPRAI

Tom Abrams Maintained (WES) at Hold with Decreased Target to $51 on, Nov 17th, 2017

by: WOPRAI

Raimo Lenschow Maintained (WDAY) at Hold with Increased Target to $117 on, Nov 17th, 2017

by: WOPRAI

Olivia Tong Maintained (SPB) at Hold with Increased Target to $719 on, Nov 17th, 2017

by: WOPRAI

Stephen Biggar Initiated (UL) at Hold on, Nov 17th, 2017

by: WOPRAI

Tom Abrams Maintained (WMB) at Buy with Decreased Target to $33 on, Nov 17th, 2017

by: WOPRAI

Christopher Horvers Downgraded (WSM) to Sell on, Nov 17th, 2017

by: WOPRAI

Curtis Nagle Maintained (WSM) at Sell with Decreased Target to $19 on, Nov 17th, 2017

by: WOPRAI

Edward Yruma Maintained (WMT) at Buy with Increased Target to $37 on, Nov 17th, 2017

by: WOPRAI

Simeon Gutman Maintained (WMT) at Hold with Increased Target to $31 on, Nov 17th, 2017

by: WOPRAI

Robert Ohmes Maintained (WMT) at Strong Buy with Increased Target to $40 on, Nov 17th, 2017

by: WOPRAI

Wayne Hood Maintained (WMT) at Hold with Increased Target to $33 on, Nov 17th, 2017

by: WOPRAI

Jason Mills Maintained (STAA) at Strong Buy with Increased Target to $20 on, Nov 17th, 2017

by: WOPRAI

Manav Patnaik Maintained (SPGI) at Buy with Increased Target to $185 on, Nov 17th, 2017

by: WOPRAI

Andrew Burns Maintained (SPWH) at Strong Buy with Decreased Target to $6.5 on, Nov 17th, 2017

by: WOPRAI

Rayna Kumar Upgraded (SQ) to Buy on, Nov 17th, 2017

by: WOPRAI

Ryan Thompson Initiated (CDE) at Buy and Held Target at $11 on, Nov 17th, 2017

by: WOPRAI

Matthew Niknam Maintained (CCI) at Strong Buy with Increased Target to $120 on, Nov 17th, 2017

by: WOPRAI

Alec Kodatsky Initiated (TECK) at Buy on, Nov 17th, 2017

by: WOPRAI

Sam Margolin Initiated (TELL) at Buy and Held Target at $14 on, Nov 17th, 2017

by: WOPRAI

George Staphos Maintained (BRC) at Sell with Increased Target to $35 on, Nov 17th, 2017

  • Mon, November 20, 2017

by: WOPRAI

Christopher Nolan Initiated (TCPC) at Strong Buy and Held Target at $17 on, Nov 20th, 2017

by: WOPRAI

Nithin Pejaver Initiated (CHGG) at Strong Buy and Held Target at $19 on, Nov 20th, 2017

by: WOPRAI

Faisel Khan Maintained (CNP) at Hold with Increased Target to $30 on, Nov 20th, 2017

by: WOPRAI

Bob Hopkins Maintained (TNDM) at Sell with Decreased Target to $2 on, Nov 20th, 2017

by: WOPRAI

Paul Condra Maintained (SQ) at Hold with Increased Target to $37 on, Nov 20th, 2017

by: WOPRAI

Greg Badishkanian Maintained (STKL) at Strong Buy with Decreased Target to $9 on, Nov 20th, 2017

by: WOPRAI

Matthew Fassler Downgraded (WMT) to Hold on, Nov 20th, 2017

by: WOPRAI

Hamed Khorsand Initiated (SMTC) at Strong Buy and Held Target at $49 on, Nov 20th, 2017

by: WOPRAI

Jeffrey Robertson Maintained (SM) at Buy with Increased Target to $23 on, Nov 20th, 2017

by: WOPRAI

Jennifer Fritzsche Upgraded (VZ) to Buy on, Nov 20th, 2017

by: WOPRAI

Ambrish Srivastava Maintained (AVGO) at Buy with Increased Target to $33 on, Nov 20th, 2017

by: WOPRAI

Faisel Khan Maintained (SWX) at Hold with Increased Target to $82 on, Nov 20th, 2017

Tazeen Ahmad Maintained (ASND) at Strong Buy with Decreased Target to $43 on, Nov 17th, 2017

Tazeen Ahmad of B of A Securities, Maintained "Ascendis Pharma A/S" (ASND) at Strong Buy with Decreased Target from $46 to $43 on, Nov 17th, 2017.

Tazeen has made no other calls on ASND in the last 4 months.



There is 1 other peer that has a rating on ASND. Out of the 1 peers that are also analyzing ASND, 0 agree with Tazeen's Rating of Hold.



This is the rating of the analyst that currently disagrees with Tazeen

  • Alethia Young of "Credit Suisse" Maintained at Buy with Increased Target to $50 on, Friday, September 22nd, 2017

Like: 👍